Form 8-K · Current report
The Travelers Companies 8-K, filed Jul 24, 2026
- Filed
- CIK
- 0000086312
- Accession no.
- 0001193125-26-316247
Summary
The Travelers Companies entered an underwriting agreement with Barclays, BofA Securities, Citigroup, J.P. Morgan Securities, and Wells Fargo Securities for the issuance and sale of $750 million aggregate principal amount of 4.950% senior notes due 2031. A prospectus supplement for the notes was filed on July 22, 2026.
Key points
- The underwriting agreement is dated July 21, 2026.
- The notes total $750,000,000 in aggregate principal amount and carry a 4.950% interest rate, maturing in 2031.
- Barclays Capital Inc., BofA Securities, Inc., Citigroup Global Markets Inc., J.P. Morgan Securities LLC, and Wells Fargo Securities, LLC are representatives of the underwriters.
- A prospectus supplement for the notes was filed on July 22, 2026.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 8.01Other Events
- 9.01Financial Statements and Exhibits
From the filing
Item 8.01 Other Events. On July 21, 2026, The Travelers Companies, Inc. (the “Company”) entered into an Underwriting Agreement (the “Agreement”) with Barclays Capital Inc., BofA Securities, Inc., Citigroup Global Markets Inc., J.P. Morgan Securities LLC and Wells Fargo Securities, LLC, as representatives of the several underwriters named in Schedule 1 of the Agreement, for the issuance and sale by the Company of $750,000,000 aggregate principal amount of the Company’s 4.950% Senior Notes due 2031 (the “Notes”). The foregoing description is qualified by reference to the Agreement, a copy of which is attached hereto as Exhibit 1.1 and incorporated by reference herein. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.